FDA Application
-
NDC Search Results on Active Ingredient: fluticasone propionate
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0054-0327-56 | Hikma Pharmaceuticals USA Inc. | ANDA203433 | HUMAN PRESCRIPTION DRUG | ANDA |
FLUTICASONE PROPIONATE | 57483-005-03 | Innovus Pharmaceuticals Inc. | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 30142-258-04 | Kroger Company | ANDA208150 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 30142-258-01 | Kroger Company | ANDA208150 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 30142-258-02 | Kroger Company | ANDA208150 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 30142-258-05 | Kroger Company | ANDA208150 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 30142-258-03 | Kroger Company | ANDA208150 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 0113-0028-01 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 0113-0285-08 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 0113-0028-02 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 0113-0285-02 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 0113-0028-09 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 0113-0028-08 | L. Perrigo Company | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 55700-680-16 | Lake Erie Medical DBA Quality Care Products LLC | ANDA078492 | HUMAN PRESCRIPTION DRUG | ANDA |
FLUTICASONE PROPIONATE | 72559-002-01 | Little Pharma, Inc. | ANDA208150 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 80267-000-09 | Live Betr LLC | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 80267-000-01 | Live Betr LLC | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 68998-600-01 | Marc Glassman, Inc. | ANDA208150 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 68998-600-02 | Marc Glassman, Inc. | ANDA208150 | HUMAN OTC DRUG | ANDA |
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE | 0037-0245-23 | Meda Pharmaceuticals Inc. | NDA202236 | HUMAN PRESCRIPTION DRUG | NDA |
FLUTICASONE PROPIONATE | 41250-634-10 | Meijer Distribution Inc | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 41250-634-03 | Meijer Distribution Inc | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 41250-634-08 | Meijer Distribution Inc | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 41250-634-01 | Meijer Distribution Inc | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 41250-634-02 | Meijer Distribution Inc | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 41250-634-09 | Meijer Distribution Inc | ANDA207957 | HUMAN OTC DRUG | ANDA |
FLUTICASONE PROPIONATE | 60432-264-15 | Morton Grove Pharmaceuticals, Inc. | ANDA078492 | HUMAN PRESCRIPTION DRUG | ANDA |
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE | 0378-3458-23 | Mylan Pharmaceuticals Inc. | NDA202236 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0378-9322-32 | Mylan Pharmaceuticals Inc. | ANDA208891 | HUMAN PRESCRIPTION DRUG | ANDA |
SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0378-9321-32 | Mylan Pharmaceuticals Inc. | ANDA208891 | HUMAN PRESCRIPTION DRUG | ANDA |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
301-330 | 331-360 | 361-390 | 391-420 | 421-426 |
-